ADHD in the News 2023-09-14

ADHD medications still in shortage, frustrating patients and doctors

[Excerpt] “Let’s just say I’m very concerned,” said Dr. Max Witznitzer, a pediatric neurologist who treats children with ADHD at University Hospitals Rainbow Babies and Children’s Hospital and Case Western Reserve University. “As the kids restart school, we’re going to see the demand for these prescriptions going up.”

Understanding the unique challenges of adult ADHD

Attention Deficit Hyperactivity Disorder (ADHD) is a common problem for people in the United States. Symptoms like difficulty focusing or finishing tasks and dealing with hyperactivity or impulsive behavior can be incredibly frustrating and affect quality of life — both for people with ADHD and for those in their lives. While ADHD is often associated with childhood, many adults struggle with ADHD too. This is complicated by the fact that symptoms can look different and the diagnostic process differs for adults. In this episode of Talk of Iowa, experts and people with ADHD discuss the challenges associated with the disorder in adults and the treatments available.

ADHD Drug Shortages Worsen as Makers Say Production Is Maxed Out

With supply constraints entering a second year, patients would like to see rules governing prescriptions loosened.

Global review reveals ADHD rates in adults

A review of studies involving more than 21 million people worldwide has revealed attention deficit hyperactivity disorder affects a staggering 3% of the global adult population. Disturbingly, nine out of 10 adults diagnosed with ADHD are not receiving the crucial treatment they require.

Delayed-Release ADHD Therapy Slightly Mitigates Slowed Growth in Kids — Youth on Jornay PM saw significantly higher weight trajectories

Meeting Coverage: Psych Congress. NASHVILLE -- Youth with attention-deficit/hyperactivity disorder (ADHD) saw mildly different growth trajectories with certain popular medications, researchers reported.

Akili is Getting out of Prescription Digital Therapeutics

Akili executives said a focus on non-prescription digital therapies removes the barriers payers place on access and creates a more sustainable business.

ADHD Research Roundup: September 8

In this Research Roundup, we explore new studies on attention-deficit/hyperactivity disorder (ADHD), with a special focus on connections between ADHD and neurodegenerative disease and interventions for children and adolescents with ADHD.

Genes and environmental factors behind severe headache identified

Cluster headache, one of the most painful diseases known to man, is genetically correlated with risk-taking behavior, ADHD, depression and musculoskeletal pain, and smoking is a causal risk factor, according to an article published in Annals of Neurology.

FAA eases burden for many pilots with ADHD history

The new guidance from the FAA to aviation medical examiners now identifies certain histories of ADHD diagnosis and/or medication usage for which AMEs can issue medical certificates. Virtually all applications for a medical certificate (FAA Form 8500-8, also known as MedXPress) that included any ADHD history previously required an extensive, expensive, and time-consuming review process typically handled by FAA staff in Washington, D.C.

Overcome ADHD Task Paralysis

KEY POINTS: Symptoms of task paralysis include overwhelm, procrastination, and low self-esteem. Improve your ability to start something by breaking it down into smaller, manageable chunks. Multitasking interferes with focus and increases distractibility.